ACS Biomarker

company

About

ACS Biomarker is an emerging biomarker development company aiming to discover and develop biomarkers that improve prognosis and management

  • 1 - 10

Details

Last Funding Type
Series Unknown
Industries
Biotechnology
Founded date
Jan 1, 2007
Number Of Employee
1 - 10
Operating Status
Active

ACS Biomarker is an emerging biomarker development company aiming to discover and develop biomarkers that improve prognosis and management of cardiac disease. Well designed biomarkers can provide major value for patients and importantly advance health care as they can signify subtle molecular mechanisms that underlie disease, so that early recognition of pathological disorders can limit the increase in healthcare cost associated with treatment of these diseases. Equally important, biomarkers are needed in therapeutic drug development to appreciate the balance between beneficial and adverse actions of novel drugs at earlier stages of development, thus increasing the efficacy of drug development.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
ACS Biomarker has raised a total of — in funding over 2 rounds. Their latest funding was raised on May 20, 2011 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 20, 2011 Series Unknown 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
ACS Biomarker is funded by 1 investors. Limburg Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Limburg Ventures Series Unknown